Lansing Street Advisors »

Regeneron Pharmaceuticals shares owned by Lansing Street Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Lansing Street Advisors from 13F filings

Historical chart of Lansing Street Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Lansing Street Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Lansing Street Advisors

Quarter filed Position value Share count Share price at filing
2023-06-30 $43k 60 718.53
2023-03-31 $49k 60 821.67
2022-12-31 $43k 60 721.48
2022-09-30 $41k 60 683.33
2022-06-30 $35k 60 583.33
2022-03-31 $44k 60 733.33

More positions owned by Lansing Street Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Chipotle Mexican Grill (CMG)
McDonald's Corporation (MCD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Sp Smcp600vl Etf (IJS)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 500 Val Etf (IVE)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Vanguard Index Fds Value Etf (VTV)

View all positions for Lansing Street Advisors

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Ubs Global Asset Management Americas
Charles Schwab Investment Management
Dimensional Fund Advisors

View all funds holding Regeneron Pharmaceuticals